Profiel
Devon Cayer is the Chief Technology Officer of Myi Diagnostics & Discovery, Inc. which is founded in 2015.
Dr. Cayer is also the founder of 1859, Inc.
Actieve functies van Devon Cayer
| Bedrijven | Functie | Begin |
|---|---|---|
Myi Diagnostics & Discovery, Inc.
 Myi Diagnostics & Discovery, Inc. BiotechnologyHealth Technology MYi Diagnostics & Discovery, Inc. provides diagnostic assays for longitudinal profiling of blood and other tissues applicable to the monitoring of healthy, disease-predisposed, and treated individuals. The firm also develops multiplexed immunocytochemical analytical platforms for assaying patient biopsies to identify the unique biomarkers that identify diseased cells. The company was founded by Nicholas J. Schork, Devon Cayer, and Kristopher L. Nazor on September 8, 2015 and is headquartered in San Diego, CA. | Oprichter | 08-09-2015 |
Eerdere bekende functies van Devon Cayer
| Bedrijven | Functie | Einde |
|---|---|---|
1859, Inc.
 1859, Inc. BiotechnologyHealth Technology 1859, Inc. operates as a biotechnology company focuses on discovery and development of next-generation therapeutics. The company was founded by Devon Cayer, Andrew MacConnell, Ramesh Ramji, and Sara Thrall and is headquartered in Del Mar, CA. | Oprichter | - |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 2 |
|---|---|
Myi Diagnostics & Discovery, Inc.
Myi Diagnostics & Discovery, Inc. BiotechnologyHealth Technology MYi Diagnostics & Discovery, Inc. provides diagnostic assays for longitudinal profiling of blood and other tissues applicable to the monitoring of healthy, disease-predisposed, and treated individuals. The firm also develops multiplexed immunocytochemical analytical platforms for assaying patient biopsies to identify the unique biomarkers that identify diseased cells. The company was founded by Nicholas J. Schork, Devon Cayer, and Kristopher L. Nazor on September 8, 2015 and is headquartered in San Diego, CA. | Health Technology |
1859, Inc.
1859, Inc. BiotechnologyHealth Technology 1859, Inc. operates as a biotechnology company focuses on discovery and development of next-generation therapeutics. The company was founded by Devon Cayer, Andrew MacConnell, Ramesh Ramji, and Sara Thrall and is headquartered in Del Mar, CA. | Health Technology |
